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This study was conducted to partially characterize and identify the purity of two major outer membrane
proteins (OMPs) (with molecular weights of 32,000 and 35,000 [32K and 35K, respectively]) of Pasteurella
haemolytica. The 35K and 32K major OMPs, designated Pasteurella outer membrane proteins A and B (PomA
and PomB, respectively), were extracted from P. haemolytica by solubilization in N-octyl polyoxyl ethylene. The
P. haemolytica strain used was a mutant serotype A1 from which the genes expressing the 30-kDa lipoproteins
had been deleted. PomA and PomB were separated and partially purified by anion-exchange chromatography.
PomA but not PomB was heat modifiable. The N-terminal amino acid sequences of the two proteins were
determined and compared with reported sequences of other known proteins. PomA had significant N-terminal
sequence homology with the OmpA protein of Escherichia coli and related proteins from other gram-negative
bacteria. Moreover, polyclonal antiserum raised against the E. coli OmpA protein reacted with this protein.
PomA was surface exposed, was conserved among P. haemolytica biotype A serotypes, and had porin activity in
planar bilayers. No homology between the N-terminal amino acid sequence of PomB and those of other known
bacterial proteins was found. Cattle vaccinated with live P. haemolytica developed a significant increase in
serum antibodies to partially purified PomA, as shown by enzyme-linked immunosorbent assays, and to
purified PomA and PomB, as detected on Western blots and by densitometry.
Bovine pneumonic pasteurellosis, also known as shipping
fever pneumonia, is the most common cause of beef cattle
losses in North America (55). Pasteurella haemolytica biotype
A serotype 1 is the principal etiologic agent of bovine pneu-
monic pasteurellosis (17, 18).
Much effort has been expended towards development of
more efficacious vaccines for the prevention of bovine pneu-
monic pasteurellosis (11, 31). To develop such vaccines, inves-
tigators have attempted to better understand P. haemolytica
virulence factors and the host immune response. Recently,
Morton et al. (29) demonstrated that cattle vaccinated with P.
haemolytica A1 outer membranes had enhanced resistance to
experimental challenge with the homologous serotype. In a
previous study, high antibody responses to P. haemolytica sa-
line-extracted proteins with molecular masses of 16, 30, 40, 42,
and 86 kDa consistently correlated with resistance to challenge
with virulent P. haemolytica (32). It was proposed that the
protein with a molecular mass of approximately 30 kDa is a
major outer membrane protein (OMP) and that this protein
may be important in inducing immunity to P. haemolytica (13).
The tandemly arranged genes for three P. haemolytica mem-
brane lipoproteins, which are approximately 28 to 30 kDa and
similar to an Escherichia coli 28-kDa lipoprotein, were recently
cloned and sequenced (13, 35). Serum antibodies to two of the
lipoproteins correlated with resistance to experimental chal-
lenge (13, 14).
Our preliminary studies suggested that another major P.
haemolyticaOMP was similar to the E. coliOmpA protein. The
outer membranes of numerous species of gram-negative bac-
teria, both enteric and nonenteric, contain major heat-modifi-
able proteins structurally similar to OmpA (4). Those bacteria
include Actinobacillus actinomycetemcomitans (52), Haemophi-
lus somnus (48), Haemophilus influenzae (33, 50), Haemophilus
ducreyi (47), Salmonella typhimurium (19), Shigella dysenteriae
(5), Neisseria gonorrhoeae (22), Pseudomonas aeruginosa (23,
54), and Serratia marcescens (6). The OmpA protein is impor-
tant in maintaining integrity of the E. coli outer membrane
(46), and it stimulates a strong antibody response (41). Also,
OmpA may play an important role in virulence, because an
OmpA-deficient mutant of E. coli K-1 had reduced virulence in
an infant rat model of bacteremia (51). Antibodies against
OmpA and several OmpA family proteins are bactericidal,
opsonic, or protective (24, 25, 28, 37). In contrast, antibodies to
the OmpA homolog of N. gonorrhoeae inhibit serum bacteri-
cidal activity (42).
The aim of the present study was to purify and characterize
two P. haemolytica OMPs that comigrate with molecular
weights of approximately 30,000 (30K) during sodium dodecyl
sulfate–12% polyacrylamide gel electrophoresis (SDS–12%
PAGE) but separate as bands of 35K and 32K on SDS–18%
PAGE gels. These proteins were characterized by determina-
tion of their N-terminal amino acid sequences and evaluation
of antigenicity by Western immunoblotting with sera from vac-
cinated and subsequently experimentally challenged cattle.
MATERIALS AND METHODS
Bacteria and culture conditions. P. haemolytica 89010807N (lpp) is a mutant
A1 serotype developed by one of us (G.L.M.) (36). The genes for expression of
three 30K lipoproteins have been detected. This mutant was selected because the
30K lipoproteins are in outer and inner membranes and could interfere with
purification or detection of OMPs under study. The bacterium was grown for 16
to 18 h on brain heart infusion (BHI) agar (Difco Laboratories, Detroit, Mich.)
containing ampicillin (10 mg/ml) and nalidixic acid (20 mg/ml) to maintain se-
lective pressure. The culture was visually inspected for purity. Several colonies
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were inoculated into 100 ml of BHI broth containing ampicillin (10 mg/ml) and
nalidixic acid (20 mg/ml) and incubated at 378C at 80 rpm on a rotary shaker
overnight. Subsequently, 100 ml of the overnight culture was inoculated into 2
liters of BHI broth containing ampicillin (10 mg/ml) and nalidixic acid (20 mg/ml)
and incubated at 378C for 16 to 18 h on a rotary shaker at 80 rpm. Bacteria were
harvested by centrifugation at 8,000 3 g for 10 min at 48C, resuspended and
washed twice with sterile phosphate-buffered saline (PBS; pH 7.2), and centri-
fuged as described above to obtain pellets. Cell pellets were stored frozen at
2208C for subsequent OMP extraction.
P. haemolytica envelope preparation. Each bacterial pellet from 2 liters of BHI
broth was resuspended in 20 ml of solution containing 10 mM Na2HPO4, 5 mM
MgSO4 (pH 7.4), DNase (50 mg/ml; Sigma Chemical Co., St. Louis, Mo.), and
RNase (50 mg/ml; Sigma Chemical Co.) and sonicated on ice (Branson Sonifier
Cell Disruptor; VWR Scientific, Danbury, Conn.) five times for 30 s each (con-
tinuously) with 30-s intervals with a double-step microtip probe (50 W) to lyse
the cells. The bacterial suspension was centrifuged at 9503 g for 10 min, and the
supernatant was collected. The supernatant was then centrifuged at 205,800 3 g
for 1 h at 48C with a 55.2 Ti rotor (Beckman Ultracentrifuge). The envelope-rich
pellet was resuspended in 10 ml of distilled H2O, and the protein concentration
was determined by bicinchoninic acid protein assay (Pierce Biochemical).
OMP extraction. Two OMPs designated Pasteurella outer membrane protein
A (PomA) (upper band) and PomB (lower band) identified by SDS-PAGE were
extracted from the envelope by a modification of a previously described n-octyl
polyoxyl ethylene (OPOE) (Octyl-POE; Bachem Bioscience Inc., Philadelphia,
Pa.) solubilization method (45). The envelope was resuspended by sonicating
three times at a concentration of 10 mg/ml in 10 mM Tris-HCl (pH 8.0)–0.5%
OPOE. After centrifugation at 154,000 3 g for 1 h at 208C, the supernatant
(designated supernatant 1) was collected. The pellet was resuspended by soni-
cation as described above in 10 mM Tris-HCl (pH 8.0)–3% OPOE. This step was
repeated twice to obtain supernatants 2 and 3. The resulting pellet was then
resuspended in 50 mM Tris-HCl (pH 8.0)–50 mM EDTA–3% OPOE by soni-
cation and centrifuged again as described above. The supernatant was collected
(supernatant 4), and the steps were repeated for the remaining pellet to obtain
supernatant 5. The resulting pellet was resuspended in 50 mM EDTA–0.4 M
NaCl–3% OPOE, sonicated, and centrifuged as described above. Supernatant 6
was collected, and the pellet was resuspended in distilled H2O, sonicated, and
centrifuged as described above. Both the pellet and the supernatant (supernatant
7) were collected. Outer membranes were also extracted separately in 0.5%
sodium N-lauryl sarcosine (Sarkosyl; Sigma Chemical Co.) as previously de-
scribed (29).
Anion-exchange purification. Supernatant 4 (which contained PomA and
PomB) was prepared for anion-exchange chromatography by equilibrating in 10
mM Tricine buffer (buffer A or binding buffer), pH 8.9, by dialysis. An anion-
exchange column (Econo-Pac High Q Cartridge; Bio-Rad, Hercules, Calif.) was
washed and equilibrated according to the manufacturer’s instructions. The sam-
ple (1 ml) was applied to the column and washed with 10 ml of buffer A. The
column was eluted by a linear gradient of 0.5 to 2 M NaCl in 10 mM Tricine
buffer (elution buffer or buffer B), pH 8.9, at a flow rate of 0.5 ml/min. Fractions
containing protein peaks were collected, concentrated by ultrafiltration with a
PM 10 filter (Amicon Inc., Beverly, Mass.), and dialyzed against 10 mM Tricine
buffer, pH 8.9. Proteins were identified in peak fractions by SDS–18% PAGE.
SDS-PAGE. Supernatants and pellets were subjected to SDS-PAGE as de-
scribed previously (16, 27). Briefly, the samples were solubilized in Laemmli
sample buffer (27) containing 5% b-mercaptoethanol and heated to 1008C for 2
to 3 min. Samples were loaded onto a 4.5% acrylamide stacking gel overlaying an
18% acrylamide resolving gel (except where stated that a 10% resolving gel was
used) and separated by electrophoresis (Mini Protean II Electrophoresis Cell;
Bio-Rad, Rockville Centre, N.Y.). Molecular weights of proteins were deter-
mined with known standards.
Anti-PomA sera.Antibodies to PomA were produced by immunizing a 4-week-
old Holstein calf with gel-purified PomA as described previously (13). Superna-
tant 4 was subjected to SDS-PAGE. PomA was identified, excised with a sterile
scalpel, and emulsified with an equal volume of Freund’s incomplete adjuvant
(FIA). The calf was immunized intramuscularly on days 0 and 15. Sera were
collected on days 0, 15, 28, and 35.
ELISA. Sera from the calf immunized with PomA and from cattle described
below were assayed for antibody responses to supernatant 6 by an enzyme-linked
immunosorbent assay (ELISA) (8). Microtiter plates were coated with superna-
tant 6 that had been concentrated and dialyzed into coating buffer at a concen-
tration of 50 ng of protein per well. Sera were diluted 1:1,000 and reacted with
the antigen. Antibody binding was detected with horseradish peroxidase (HRP)-
conjugated affinity-purified rabbit anti-bovine immunoglobulin G (IgG) (Pel-
Freez, Rogers, Ark.). All assays were done in triplicate. Data were reported as
mean optical densities at 490 nm (OD490) 6 standard deviations.
Western immunoblots. Extracts were subjected to SDS-PAGE, electrophoreti-
cally transferred to nitrocellulose membranes as previously described (16), and
probed with calf anti-P. haemolytica PomA serum and rabbit anti-E. coli OmpA
serum (the latter was kindly provided by Ulf Henning, Tübingen, Germany) (20,
43). The antibody complexes were detected by incubating with HRP-conjugated
affinity-purified goat anti-rabbit IgG (Pel-Freez) or HRP-conjugated affinity-
purified rabbit anti-bovine IgG (Pel-Freez). Serum samples obtained from cattle
vaccinated with P. haemolytica (described below) were evaluated on Western
immunoblots against PomA and PomB as previously described (13, 14, 31, 40).
Briefly, supernatant 6 containing mostly PomA from OPOE extraction and
anion-exchange-purified PomB from supernatant 4 were subjected to SDS-
PAGE, transferred to nitrocellulose membranes, and probed with a 1:25 dilution
of cattle serum for 2 h. Immune complexes were detected with the HRP-conju-
gated rabbit anti-bovine IgG (8). Color reactions were developed with 0.05%
4-chloro-1-naphthol dissolved in 20 ml of ice-cold methanol and 0.05% H2O2 in
100 ml of Tris-buffered saline, pH 7.4.
Heat modifiability. To determine the heat modifiability of proteins, fractions
were solubilized in sample buffer at 37 or 1008C for 10 min and subjected to
SDS-PAGE.
Surface exposure of PomA. To determine surface exposure of proteins, P.
haemolytica cells (1 ml) in the mid-logarithmic phase of growth were collected by
centrifugation and washed in an equal volume of enzyme buffer (0.08 M Tris-HCl
[pH 8.0], 0.1 M CaCl2). Cells were resuspended in 0.25 ml of enzyme buffer, and
50 mg of chymotrypsin (Sigma) in 0.005 ml of enzyme buffer was added (40).
Negative controls received an equal volume of enzyme buffer with no enzyme.
Cells were incubated on a rotary shaker (120 rpm) for 1 h at 378C, collected by
centrifugation, and washed with 1 ml of PBS. For SDS-PAGE, enzyme-treated
and control cells at the same concentration based on OD650 readings were
resuspended in 0.05 ml of PBS and 0.05 ml of Laemmli sample buffer and heated
at 958C for 5 min before SDS–10% PAGE and Western blot analysis (40).
N-terminal amino acid sequencing. Supernatant 4 was subjected to SDS-
PAGE, electrophoretically transferred to a polyvinylidene difluoride membrane
(Bio-Rad, Hercules, Calif.), and stained with Coomassie brilliant blue R-250
(Bio-Rad, Hercules, Calif.). The bands were identified by comparison with mo-
lecular weight markers. Strips of membrane containing PomA and PomB were
excised and subjected to N-terminal amino acid sequencing (Molecular Biology
Resource Facility, University of Oklahoma Health Sciences Center).
Serotype specificity of PomA. To determine the conservation of PomA in
different P. haemolytica serotypes, whole-cell lysates of A biotypes (serotypes 1,
2, 5, 6, 7, 8, 9, 10, 12, 13, and 14) and strain 89010807N (lpp) were solubilized in
sample buffer at 1008C for 2 min and subjected to SDS-PAGE. Proteins were
transferred to nitrocellulose membranes and probed with a dilution of 1:200 calf
anti-PomA serum to detect OmpA family protein bands.
Planar bilayer methods. Planar bilayers were made from 1.5% oxidized cho-
lesterol (kindly provided by R. Benz, Würzburg, Germany) in n-decane. An
applied voltage of 50 mV and a bathing solution of 1 M KCl were employed. The
PomA protein was added to the bathing solution on one side of the bilayer to a
final concentration of 60 ng/ml. All other experimental conditions were as pre-
viously described for outer membrane porin protein F of P. aeruginosa (OprF)
(53). Controls were nonporin and standard porin protein preparations from E.
coli and P. aeruginosa.
Antibody responses in cattle. Antibody responses to partially purified PomA
(supernatant 6) were quantified by ELISA. Antibody responses to anion-ex-
change-purified PomA and PomB were quantified on Western immunoblots by
using densitometry as used previously in our laboratories (8, 13, 14, 32, 40).
Serum samples were obtained from 20 weanling cattle that had been previously
experimentally vaccinated and challenged with P. haemolytica A1 (9, 10, 12, 39).
Cattle were equally divided among four groups and vaccinated twice subcutane-
ously (days 0 and 7) with either PBS, formalin-killed P. haemolytica with alumi-
num hydroxide (bacterin-AlOH), formalin-killed P. haemolytica with FIA (bac-
terin-FIA), or 109 CFU of live P. haemolytica. On day 21, cattle were challenged
transthoracically in the caudal lung lobes with 5 3 109 CFU of P. haemolytica
(39). Four days later, cattle were euthanatized, and lung lesion scores ranging
from 0 to 20 were assigned based on the criteria of intensity and spread of lesion
(the higher the score was, the more intense the lesion was) (39).
Reactivity of day 0 and day 21 sera to PomA and PomB on Western immu-
noblots was quantified by measuring the intensity of the bands with a one-
dimensional-gel scanner (Protein Database Inc., Huntington Station, N.Y.). The
blots were scanned, and the OD (trace OD times millimeters) were determined
as indirect measurements of the antibody responses (8, 13, 14, 32, 40).
Statistical analysis. Mean values for trace OD times millimeters (mean OD
values) for PomA and PomB were compared among the vaccine groups by
two-sample t tests (2). Within groups, mean OD values were compared by paired
t tests. Linear regression analysis was used to correlate antibody responses as
measured by ELISA or Western blot-densitometry and lesion scores (31).
RESULTS
Protein extraction. Fractionation of P. haemolytica
89010807N (lpp) by differential solubilization in OPOE deter-
gent resulted in seven supernatant fractions and an insoluble
pellet. SDS-PAGE of all the supernatants and the pellet
showed that supernatant fractions 4, 5, and 6 contained several
membrane proteins with molecular masses ranging from 106 to
18 kDa (Fig. 1). At approximately 35K, a doublet of bands was
seen in fractions 4, 5, and 6 with a progressive decrease in
concentration of the lower band. The upper band (designated
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PomA) was prominent, and the lower band (designated PomB)
was much less so. The apparent molecular weight of PomA and
PomB varied with the percentage of the resolving gels used.
We observed that PomA and PomB comigrated at approxi-
mately 30K on 12% gels. To electrophoretically separate these
protein bands, we used SDS–18% PAGE. This resolved these
proteins into two bands corresponding to molecular weights of
35K (PomA) and 32K (PomB) (Fig. 1).
To test whether the two protein bands represented different
proteins or were different forms of the same protein, we de-
termined the N-terminal amino acid sequences. This analysis
suggested that the two bands represented two different pro-
teins. The N-terminal amino acid sequence of PomA is shown
in Table 1. Comparison of this sequence with published se-
quences by using the BLAST network service (1) revealed that
PomA had 60% identity with the N-terminal amino acid se-
quence of the E. coli OmpA protein (4) and varied from 60 to
100% identity with related proteins from several other gram-
negative bacteria (Table 1) (1, 5, 6, 19, 33, 34, 47, 52).
Further evidence that PomA was related to E. coli OmpA
was obtained by Western immunoblot analysis (Fig. 2). Rabbit
antiserum against E. coliOmpA reacted strongly with PomA of
P. haemolytica. Calf anti-P. haemolytica PomA sera also re-
acted with the same band.
The molecular weight of P. haemolytica PomB was 32K. The
N-terminal amino acid sequence was ADTIG
FVDPSYVLENHPVLLDAS. A search of protein sequence
databases with the BLAST network service (1) failed to find
any substantial homology with other known bacterial proteins.
Heat modifiability of PomA. In undialyzed supernatant 4 or
supernatant 6 samples evaluated by SDS-PAGE, PomA had an
apparent molecular weight of 35K after incubation at 37 and
1008C. However, SDS-PAGE analysis of PomA present in di-
alyzed (against deionized water) supernatant 4 fraction and
incubated in sample buffer at 378C demonstrated two antigenic
bands, one with a molecular weight of 35K and the other at
40K (Fig. 2). In contrast, solubilization of dialyzed PomA at
1008C for 10 min resulted in an apparent molecular weight of
40K. On Western immunoblots, both 35K and 40K bands were
identified with anti-E. coli OmpA and calf anti-P. haemolytica
PomA sera, indicating that they represent a single protein.
N-terminal amino acid sequencing of both the 35K and 40K
bands demonstrated identical sequences. PomB had the same
FIG. 1. SDS-PAGE (18% acrylamide gel, silver stain) showing the OMP
bands (including PomA and PomB) of P. haemolytica in various OPOE-extracted
supernatants and Sarkosyl-extracted OMPs. Lane 1, OMPs of P. haemolytica
89010807N (lpp); lane 2, supernatant 4; lane 3, supernatant 5; lane 4, supernatant
6. Upper arrowhead, PomA; lower arrowhead, PomB.
FIG. 2. Western blot showing reactivity of rabbit anti-E. coli OmpA sera and
calf anti-P. haemolytica (OmpA family protein) PomA sera with PomA of P.
haemolytica. Lanes 1 and 2, loaded with supernatant 4 (dialyzed against deion-
ized water) solubilized in sample buffer at 100 or 378C, respectively, and probed
with anti-E. coli OmpA sera (1:200 dilution). (In the dialyzed fraction the PomA
is partially heat modified.) Lanes 3 and 4, same as in lanes 1 and 2 except probed
with calf anti-P. haemolytica OmpA family protein (PomA) serum (1:200 dilu-
tion). Upper arrowhead, heat-modified PomA; lower arrowhead, unmodified
PomA.
TABLE 1. Comparison of N-terminal amino acid sequence of PomA from P. haemolytica A1 with the sequences for E. coli OmpA and
OmpA-related proteins
Protein (reference[s]) Sequence % Identity
Pasteurella haemolytica PomA APQANTFYAGAKAGWASFHD
Haemophilus influenzae P5 (1, 33) APQENTFYAGYKAGQASFHD 85.0a
Haemophilus influenzae fimbrial (1) APQENTFYAGVKAGQGSFHD 80.0a
Enterobacter aerogenes OMP A (1) APKDNTWYAGGKLGWSQFHD 65.0a
Salmonella typhimurium OMP A (1, 19) APKDNTWYAGAKLGWSQYHD 65.0a
Shigella dysenteriae OMP A (1, 5) APKDNTWYTGAKLGWSQYHD 60.0a
Escherichia coli OMP A (1, 3) APKDNTWYTGAKLGWSQYHD 60.0a
Serratia marcescens (1, 6) APKDNTWYTGAKLGWSQYHD 60.0a
Actinobacillus actinomycetemcomitans 29 kDa (51) APQANTFYAGAKAb 100.0d
Haemophilus somnus OMP (47) APQANTFYAGAKc 100.0e
Haemophilus ducreyi MOMP (46) APQADTFYVGAKAb 83.3d
a Identity of 20 amino acids with the P. haemolytica PomA sequence.
b Sequence of the next eight amino acids not available.
c Sequence of the next nine amino acids not available.
d Identity of 13 amino acids with the P. haemolytica PomA sequence.
e Identity of 12 amino acids with the P. haemolytica PomA sequence.
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molecular weight at both at 37 and 1008C in dialyzed and
undialyzed preparations (data not shown).
Surface exposure of PomA. Because many of the properties
of PomA were similar to those of E. coli OmpA, we wanted to
know whether PomA was surface exposed like other members
of the OmpA family (7, 21, 38). To determine the presence of
surface-exposed regions of PomA, intact P. haemolytica cells
were treated with chymotrypsin. Whole-cell lysates of pro-
tease-treated cells were examined by Western immunoblot
analysis with anti-E. coli OmpA serum (Fig. 3). Anti-OmpA
serum identified two bands, one at approximately 30K and one
at 40K, by SDS–10% PAGE; the latter most likely was the
heat-modified form. Comparison of protease-treated and un-
treated lysates indicated that chymotrypsin treatment resulted
in a loss of immunoreactivity with anti-E. coli OmpA sera (39).
This indicated surface exposure of PomA.
Serotype specificity of PomA. On Western immunoblots
(Fig. 4) of whole-cell lysates of different serotypes of P. hae-
molytica biotype A, one to two bands were identified with
bovine anti-P. haemolytica PomA sera. For serotypes 1 to 8 and
11, 13, and 14, the positive bands corresponded to unmodified
(35K) forms of PomA. For serotype 12, a faintly staining band
was identified at 35K and an intensely staining band was iden-
tified at 37K. Our strain of serotype 9 has a different OMP
pattern, and several bands stained positively with anti-PomA
serum. This is consistent with the recently published data of
Morton et al. (30), which showed that the outer membrane
profile of this serotype 9 strain is different from those of other
serotypes of P. haemolytica biotype A. These results suggest
that all P. haemolytica biotype A serotypes contain OmpA
family proteins.
Anion-exchange purification. Further OPOE extraction of
supernatant 4 yielded partial purification of PomA. PomB was
greatly reduced in those extractions (supernatants 5 and 6). To
determine if PomA and PomB could be separated and each
partially purified from supernatant 4, we used anion-exchange
chromatography. All proteins in supernatant 4 bound to the
column (pH 8.9). Proteins were eluted with a linear gradient of
elution buffer resulting in two protein peaks (Fig. 5). These
proteins were identified in concentrated and dialyzed peak
fractions by SDS-PAGE (Fig. 6). PomB eluted with a salt
concentration gradient of 0.62 to 0.66 M NaCl, and PomA
eluted with a salt concentration gradient of 1.98 to 2.0 M NaCl.
Thus, it was possible to separate and partially purify PomA and
PomB effectively by anion-exchange chromatography. N-ter-
minal sequencing confirmed the separation of the two proteins.
Porin activity of PomA. Previous data have indicated that
other members of the OmpA superfamily, including OprF (53)
and OmpA itself (44), predominantly form small channels of
around 300-pS conductance in 1 M KCl. Similar studies with
PomA revealed that this protein also formed small ion-perme-
able channels with a single-channel conductance of 105 6 34
pS in 1 M KCl. Many of these channels had quite short half-
FIG. 3. Western blot showing the surface exposure of PomA protein of P.
haemolytica. Polyclonal antiserum directed against E. coli OmpA was used as the
primary antibody. Left lane, whole-cell lysates of chymotrypsin-treated P. hae-
molytica cells showing cleavage of the PomA protein (;30 kDa on SDS–10%
PAGE gels) resulting in loss of immunoreactivity; right lane, whole cells of P.
haemolytica treated with enzyme buffer only showing intact proteins recognized
by E. coli OmpA antisera.
FIG. 4. Western blot showing conservation of OmpA family PomA protein in different P. haemolytica A serotypes. The whole-cell lysates of different serotypes and
supernatant 4 were subjected to SDS–18% PAGE, transferred to a membrane, and probed with calf anti-P. haemolytica (OmpA family protein) PomA serum (1:250
dilution). This serum detected the PomA-equivalent bands in all serotypes. The numbers above the lanes represent serotypes. Lane p, P. haemolytica 89010807N (lpp);
lane MW, prestained molecular weight markers (marked in thousands on the right).
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lives of around 10 s or less, and at higher concentrations of
protein in the chamber, events as large as 600 pS were ob-
served, possibly due to aggregation or coincident insertion of
channels into the bilayer. Thus, these data revealed that
PomA, like other members of the OmpA superfamily, had
porin activity.
Antibody responses of cattle. To evaluate the antigenicity of
PomA and PomB for cattle, antibody responses (OD values) to
supernatant 6, purified PomA, and purified PomB were deter-
mined in sera from cattle in four vaccinated groups (8, 13, 14,
32, 40). There were significant differences between the mean
lesion scores for PBS-vaccinated versus live-organism-vacci-
nated (P , 0.05), PBS-vaccinated versus bacterin-FIA-vacci-
nated (P , 0.05), and PBS-vaccinated versus bacterin-AlOH-
vaccinated (P , 0.05) cattle (Table 2). Vaccination of cattle
with bacterin-FIA or live bacteria resulted in significant (P ,
0.05) increases in antibody responses to supernatant 6 as mea-
sured by ELISA. Antibody responses did not significantly in-
crease for the PBS and bacterin-AlOH groups. Antibody re-
sponses on day 21 were significantly greater (P , 0.05) for the
groups vaccinated with bacterin-FIA and live bacteria com-
pared to either the bacterin-AlOH or PBS group.
Antibody responses to purified PomA, as measured by West-
ern blot-densitometry, significantly increased (P , 0.05) be-
tween days 0 and 21 for all groups. There were no significant
differences (P . 0.05) between mean antibody responses
against purified PomA (day 21) among P. haemolytica-vacci-
nated groups and PBS control groups. The antibody response
of vaccinates receiving live bacteria to purified PomB was sig-
nificantly (P , 0.05) greater on day 21 than on day 0. Signif-
icant differences (P , 0.05) were seen between antibody re-
sponses to PomB (day 21) for groups receiving PBS and live
bacteria. There were no significant differences (P . 0.05) in
antibody responses to PomB between PBS- and bacterin-
AlOH-vaccinated or PBS- and bacterin-FIA-vaccinated
groups.
Regression analysis indicated a strong correlation (r 5
20.645; P , 0.002) between high antibody responses to super-
natant 6 and resistance to challenge. The correlations between
high antibody responses to purified PomA and to purified
PomB and resistance to challenge were less significant than
those to supernatant 6 (r 5 20.439 and r 5 20.458, respec-
tively; P , 0.05).
DISCUSSION
In this study, we partially purified and characterized two
membrane proteins of P. haemolytica, termed PomA and
PomB (35K and 32K, respectively), which eluted in fractions 4,
5, and 6 of an OPOE OMP extraction. Previous studies (35)
identified three lipoproteins (28 to 30 kDa) that are in the
Sarkosyl-soluble and -insoluble fractions of P. haemolytica A1.
To prevent interference of these proteins in identification and
characterization of PomA and PomB, we used P. haemolytica
lipoprotein-deficient mutant 89010807N (lpp) (36), which no
longer produces these three lipoproteins. Even though super-
natant 6 yielded partially purified PomA, it also had relatively
small quantities of PomB. Hence, for future studies of the
OmpA family protein of P. haemolytica, anion-exchange chro-
matography could be used to separate and purify PomA and
PomB from supernatant 4.
FIG. 5. Anion-exchange purification of PomA (peak 1) and PomB (peak 2) with binding buffer (10 mM Tricine [pH 8.9]) and elution buffer (10 mM Tricine, 2 M
NaCl [pH 8.75]).
FIG. 6. SDS–18% PAGE showing different eluted protein peak fractions on
anion-exchange chromatography (silver stain). Lane 1, outer membrane; lane 2,
peak 1 containing PomB; lane 3, peak 2 containing PomA. Upper arrowhead,
PomA; lower arrowhead, PomB.
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The N-terminal sequence of PomA and immunoblot analysis
data indicate that this protein has substantial homology and
shares epitopes with E. coli OmpA. Comparisons of the N-
terminal amino acid sequence of PomA with sequences from
OmpA family proteins from seven other bacterial species in-
dicated that PomA is probably a member of the OmpA family
of proteins. These are major bacterial OMPs and are con-
served among many gram-negative bacteria. In addition, im-
munoreactive OmpA family proteins were found in each of the
P. haemolytica biotype A serotypes, indicating conservation
among P. haemolytica serotypes.
The N-terminal amino acid sequences for P. haemolytica
PomA and PomB were different. We compared the sequence
of PomB with other portions of the published sequence of E.
coli OmpA and found no homology. Therefore, it is unlikely
that PomB is a cleaved portion of PomA or a member of the
OmpA family of proteins.
The outer membranes of several strains of E. coli, other
enteric bacteria, and a variety of nonenteric gram-negative
bacteria contain major heat-modifiable proteins similar to
OmpA of E. coli (4). Several heat-modifiable proteins have
been identified in P. haemolytica (26). In supernatant 4 dia-
lyzed against deionized water, PomA appeared in two forms,
35K and 40K, when incubated at 378C. Like several other
OmpA family proteins, PomA was heat modifiable such that
incubation for 10 min at 1008C resulted in only a 40K form
being present. PomA, however, migrated at 35K and was not
heat modifiable unless the supernatant was dialyzed against
deionized water. This behavior is most likely due to removal of
components that stabilize the protein in its heat-unmodified
form. Chymotrypsin treatment of P. haemolytica indicated that
PomA is surface exposed like E. coli OmpA. Functional char-
acterization of PomA revealed that it had porin activity. All
these properties of PomA support its inclusion in the OmpA
family of proteins.
OmpA proteins confer stability to outer membranes (46),
serve as receptors for certain bacteriophages (15, 49), and
stabilize mating aggregates formed during F pilus-mediated
conjugation (49). A recent study demonstrated that OmpA is a
factor in determining resistance to complement-mediated se-
rum killing of a virulent strain of E. coli K-1 (51). However, the
finding that antibodies to the OmpA family protein in N. gon-
orrhoeae inhibit serum bactericidal activity indicates that anti-
bodies to this group of proteins could be detrimental to host
defenses (42). To determine the potential role of P. haemo-
lytica PomA and PomB in immunity, antibody responses to
supernatant 6, which contains mainly PomA, and to purified
PomA and PomB were determined in sera from cattle that had
been experimentally vaccinated with live or killed P. haemo-
lytica. In an ELISA with supernatant 6 (predominately PomA),
there were significant increases in antibody response in all P.
haemolytica vaccinates. Antibody responses in control cattle
remained unchanged. As shown by Western blotting-densito-
metry, antibody responses to purified PomA increased for P.
haemolytica and for PBS vaccinates. In addition, the correla-
tion between high antibody responses and resistance to chal-
lenge was markedly less for the antibodies measured by West-
ern blot-densitometry than for those measured by ELISA. The
reasons for these findings are not known with surety. During
the course of cattle experiments, one frequently finds an in-
crease in antibodies to P. haemolytica due to inhalation of P.
haemolytica endogenous to the nasal flora. It is unlikely, how-
ever, that the increase in antibodies to purified PomA detected
in the PBS vaccinates was due to antibodies to endogenous P.
haemolytica, because the responses to PomB and to superna-
tant 6 did not increase in that group of cattle.
Other gram-negative bacteria are part of the normal nasal
and intestinal flora and could have stimulated antibodies to
OmpA family proteins that cross-reacted with PomA. Those
could have been detected in sera from the PBS vaccinates. This
scenario is possible; however, we found that Western blots
against E. coli whole-cell lysates using sera from PBS vacci-
nates had similar reactions to proteins in the 30K to 40K range
for the day 21 and day 0 sera (data not shown). Therefore, it is
unlikely that the antibody responses to purified PomA that
were detected by Western blotting-densitometry are cross-re-
active antibodies to E. coli OmpA.
The results of this experiment raise questions about the
potential immunologic significance of antibody responses to
PomA. By Western blot-densitometry, the PBS-vaccinated
controls had higher quantities of antibodies to PomA but were
more susceptible to challenge than the bacterin-AlOH group.
A high antibody response to PomA, as measured with these
Western blots, was not a good indicator of any potential pro-
tection against experimental P. haemolytica challenge. How-
ever, the potential for cattle to develop antibodies to OmpA
family proteins, other than from E. coli, and for those antibod-
ies to cross-react with PomA and be detected in Western blots
must still be considered. Therefore, characterization of the
functional immune response to PomA is needed to determine
if PomA has immunologic significance in bovine pneumonic
pasteurellosis.
TABLE 2. Lesion scores and serum antibody responses to supernatant 6, purified PomA, and purified PomB of P. haemolytica for cattle (five





Mean 6 SD antibody response to:
Supernatant 6a PomAb PomBb
Day 0 Day 21 Day 0 Day 21 Day 0 Day 21
PBS 12.0 6 4.1 0.230 6 0.211 0.248 6 0.099 0.066 6 0.147 0.361 6 0.113d 0.031 6 0.049 0.019 6 0.015
Bacterin-AlOH 6.5 6 2.4c 0.128 6 0.066 0.302 6 0.183 0.000 6 0.000 0.318 6 0.074d 0.026 6 0.029 0.090 6 0.080
Bacterin-FIA 3.8 6 4.3c 0.292 6 0.377 0.856 6 0.342c,d,e 0.000 6 0.000 0.458 6 0.207d 0.009 6 0.013 0.038 6 0.037
Live P. haemolytica 3.6 6 2.0c 0.296 6 0.186 0.879 6 0.327c,d,e 0.040 6 0.102 0.520 6 0.166d 0.008 6 0.015 0.277 6 0.180c,d
a Trace OD490 as determined by ELISA.
b Trace OD times millimeters, as determined by quantitative Western immunoblot analysis.
c Significantly different (P , 0.05) from value for PBS group.
d Significantly different (P , 0.05) from day 0 value.
e Significantly different (P , 0.05) from value for bacterin-AlOH group.
216 MAHASRESHTI ET AL. INFECT. IMMUN.
ACKNOWLEDGMENTS
This study was funded in part by grant 94-04 from the AVMA
Foundation, Oklahoma Agricultural Experimental Station project
OKL01438, and a grant from the Medical Research Council of Canada
(R.E.W.H).
We thank Sherl Holesko for assistance in typing and graphing.
REFERENCES
1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990.
Basic local alignment search tool. J. Mol. Biol. 215:403–410.
2. Bailey, N. T. J. 1981. Statistical methods in biology, p. 77–89. John Wiley,
New York, N.Y.
3. Beck, E., and E. Bremer. 1980. Nucleotide sequence of the gene ompA
coding the outer membrane protein II of Escherichia coliK-12. Nucleic Acids
Res. 8:3011–3024.
4. Beher, M. G., C. A. Schnaitman, and A. P. Pugsley. 1980. Major heat-
modifiable outer membrane protein in gram-negative bacteria: comparison
with the OmpA protein of Escherichia coli. J. Bacteriol. 143:906–913.
5. Braun, G., and S. T. Cole. 1982. The nucleotide sequence coding for the
major outer membrane protein OmpA of Shigella dysenteriae. Nucleic Acids
Res. 10:2367–2378.
6. Braun, G., and S. T. Cole. 1984. DNA sequence analysis of the Serratia
marcescens ompA gene: implications for the organisation of an enterobac-
terial outer membrane protein. Mol. Gen. Genet. 195:321–328.
7. Champion, C. I., J. N. Miller, M. A. Lovett, and D. R. Blanco. 1990. Cloning,
sequencing, and expression of two class B endoflagellar genes of Treponema
pallidum subsp. pallidum encoding the 34.5- and 31.0-kilodalton proteins.
Infect. Immun. 58:1697–1704.
8. Confer, A. W., R. D. McCraw, J. A. Durham, R. J. Morton, and R. J.
Panciera. 1995. Serum antibody responses of cattle to iron-regulated outer
membrane proteins of Pasteurella haemolytica A1. Vet. Immunol. Immuno-
pathol. 47:101–110.
9. Confer, A. W., R. J. Panciera, M. J. Gentry, and R. W. Fulton. 1986. Immu-
nologic response and resistance to experimental pneumonic pasteurellosis in
cattle vaccinated with varying doses of lyophilised Pasteurella haemolytica.
Am. J. Vet. Res. 47:1853–1857.
10. Confer, A. W., R. J. Panciera, M. J. Gentry, and R. W. Fulton. 1987. Immu-
nologic response to Pasteurella haemolytica and resistance against experi-
mental bovine pneumonic pasteurellosis, induced by bacterins in oil adju-
vants. Am. J. Vet. Res. 48:163–168.
11. Confer, A. W., R. J. Panciera, and D. A. Mosier. 1988. Bovine pneumonic
pasteurellosis immunity to Pasteurella haemolytica. J. Am. Vet. Med. Assoc.
193:1308–1316.
12. Confer, A. W., R. J. Panciera, and D. A. Mosier. 1986. Serum antibodies to
Pasteurella haemolytica lipopolysaccharide: relationship to experimental bo-
vine pneumonic pasteurellosis. Am. J. Vet. Res. 47:1134–1138.
13. Craven, R. C., A. W. Confer, and M. J. Gentry. 1991. Cloning and expression
of a 30 kDa surface antigen of Pasteurella haemolytica. Vet. Microbiol.
27:63–78.
14. Dabo, S. M., A. W. Confer, D. Styre, and G. L. Murphy. 1994. Expression,
purification and immunological analysis of three Pasteurella haemolytica A1
28–30 kDa lipoproteins. Microb. Pathog. 17:149–158.
15. Datta, D. B., B. Arden, and U. Henning. 1977. Major proteins of the Esch-
erichia coli outer cell envelope membrane as bacteriophage receptors. J.
Bacteriol. 131:821–829.
16. Davies, R. L., R. Parton, J. G. Coote, H. A. Gibbs, and J. H. Freer. 1994.
Evaluation of different methods for detection of outer membrane proteins
and lipopolylaccharides of Pasteurella haemolytica by immunoblotting. J. Im-
munol. Methods 167:35–45.
17. Frank, G. H. 1986. The role of P. haemolytica in the bovine respiratory
disease complex. Vet. Med. 81:838–846.
18. Frank, G. H. 1989. Pasteurellosis of cattle, p. 197–222. In C. Adlam and J. M.
Rutter (ed.), Pasteurella and pasteurellosis. Academic Press Ltd., London,
United Kingdom.
19. Freudl, R., and S. T. Cole. 1983. Cloning and molecular characterization of
the ompA gene from Salmonella typhimurium. Eur. J. Biochem. 134:497–502.
20. Freudl, R., G. Braun, I. Hindennac, and U. Henning. 1985. Lethal mutations
in the structural gene of an outer membrane protein (ompA) of Escherichia
coli K-12. Mol. Gen. Genet. 201:76–81.
21. Freudl, R., S. MacIntyre, M. Degen, and U. Henning. 1986. Cell surface
exposure of the outer membrane protein OmpA Escherichia coli K-12. J.
Mol. Biol. 188:491–494.
22. Gotschlich, E. C., M. Seiff, and M. S. Blake. 1987. The DNA sequence of the
structural gene of gonococcal protein III and the flanking region containing
a repetitive sequence. Homology of protein III with enterobacterial OmpA
proteins. J. Exp. Med. 165:471–482.
23. Hancock, R. E. W., and A. M. Carey. 1979. Outer membrane of Pseudomonas
aeruginosa: heat- and 2-mercaptoethanol-modifiable proteins. J. Bacteriol.
140:902–910.
24. Hughes, E. E., L. B. Gilleland, and H. E. Gilleland. 1992. Synthetic peptides
representing epitopes of outer membrane protein F of Pseudomonas aerugi-
nosa that elicit antibodies reactive with whole cells of heterologous immu-
notype strains of P. aeruginosa. Infect. Immun. 60:3497–3503.
25. Ichihara, S., M. Hussain, and S. Mizushima. 1981. Characterization of new
membrane lipoproteins and their precursors of Escherichia coli. J. Biol.
Chem. 256:3125–3129.
26. Knights, J. M., C. Adlam, and P. Owen. 1990. Characterization of envelope
proteins from Pasteurella haemolytica and Pasteurella multocida. J. Gen.
Microbiol. 136:495–505.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature (London) 227:680–685.
28. Mathews, G. J. M., and H. E. Gilleland. 1987. Outer membrane protein F
(porin) preparation of Pseudomonas aeruginosa as a protective vaccine
against heterologous immunotype strains in a burned mouse model. J. Infect.
Dis. 155:1282–1291.
29. Morton, R. J., R. J. Panciera, R. W. Fulton, G. H. Frank, S. A. Ewing, J. T.
Homer, and A. W. Confer. 1995. Vaccination of cattle with outer membrane
protein-enriched fractions of Pasteurella haemolytica and resistance to ex-
perimental challenge. Am. J. Vet. Res. 56:875–879.
30. Morton, R. J., K. R. Simons, and A. W. Confer. 1996. Major outer membrane
proteins of Pasteurella haemolytica serovars 1-15: comparison of preparation
techniques and surface-exposed proteins on selected serovars. Vet. Micro-
biol. 51:319–330.
31. Mosier, D. A., A. W. Confer, and R. J. Panciera. 1989. The evolution of
vaccines for pneumonic pasteurellosis. Res. Vet. Sci. 47:1–11.
32. Mosier, D. A., K. R. Simons, A. W. Confer, R. J. Panciera, and K. D.
Clinkenbeard. 1989. Pasteurella haemolytica antigens associated with resis-
tance to pneumonic pasteurellosis. Infect. Immun. 57:711–776.
33. Munson, R. S., Jr., and D. M. Granoff. 1985. Purification and partial char-
acterization of outer membrane proteins P5 and P6 from Haemophilus in-
fluenzae type b. Infect. Immun. 49:544–549.
34. Munson, R. S., Jr., S. Grass, and R. West. 1993. Molecular cloning and
sequence of the gene for outer membrane protein P5 of Haemophilus influ-
enzae. Infect. Immun. 61:4017–4020.
35. Murphy, G. L., and L. C. Whitworth. 1993. Analysis of tandem, multiple
genes encoding 30-kDa membrane proteins in Pasteurella haemolytica A1.
Gene 129:107–111.
36. Murphy, G. L., and L. C. Whitworth. 1994. Construction of isogenic mutants
of Pasteurella haemolytica by allelic replacement. Gene 148:101–105.
37. Murphy, T. F., L. C. Bartos, P. A. Rice, M. B. Nelson, K. C. Duda, and M. A.
Apicella. 1986. Identification of a 16,600-dalton outer membrane protein on
non-typableHaemophilus influenzae as a target for human serum bactericidal
antibody. J. Clin. Invest. 78:1020–1027.
38. Murphy, T. F., M. B. Nelson, K. C. Dudas, J. M. Mylotte, and M. A. Apicella.
1985. Identification of a specific epitope of Haemophilus influenzae on a
16,600-dalton outer membrane protein. J. Infect. Dis. 152:1300–1301.
39. Panciera, R. J., R. E. Corstvet, A. W. Confer, and C. N. Gresham. 1984.
Bovine pneumonic pasteurellosis: effect of vaccination with live Pasteurella
species. Am. J. Vet. Res. 45:2538–2542.
40. Pandher, K., and G. L. Murphy. 1996. Genetic and immunologic analysis of
a 38 kDa surface exposed lipoprotein of Pasteurella haemolytica A1. Vet.
Microbiol. 51:331–341.
41. Puohiniemi, R., M. Karvonen, J. Vuopio-Varkila, A. Muotiala, I. M.
Helander, and M. Sarvas. 1990. A strong antibody response to the periplas-
mic C-terminal domain of the OmpA protein of Escherichia coli is produced
by immunization with purified OmpA or with whole E. coli or Salmonella
typhimurium bacteria [sic]. Infect. Immun. 58:1691–1696.
42. Rice, P. A., H. E. Vayo, M. R. Tam, and M. S. Blake. 1986. Immunoglobulin
G antibodies directed against protein III block killing of serum-resistant
Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164:1735–1748.
43. Ried, G., R. Koebnik, I. Hindennach, B. Mutschler, and U. Henning. 1994.
Membrane topology and assembly of the outer membrane protein OmpA of
Escherichia coli K12. Mol. Gen. Genet. 243:127–135.
44. Saint, N., E. De, S. Juliens, N. Orange, and G. Molle. 1993. Ionophore
properties of OmpA of Escherichia coli. Biochim. Biophys. Acta 1145:119–
123.
45. Siehnel, R. J., E. Christine, and R. E. W. Hancock. 1992. Polyphosphate-
selective porin OprO of Pseudomonas aeruginosa: expression, purification
and sequence. Mol. Microbiol. 6:2319–2326.
46. Sonntag, I., H. Schwartz, Y. Hirota, and U. Henning. 1978. Cell envelope and
shape ofEscherichia coli: multiple mutants missing the outer membrane lipopro-
tein and other major outer membrane proteins. J. Bacteriol. 136:280–285.
47. Spinola, S. M., G. E. Griffiths, K. L. Shanks, and M. S. Blake. 1993. The
major outer membrane protein of Haemophilus ducreyi is a member of the
OmpA family of proteins. Infect. Immun. 61:1346–1351.
48. Tagawa, Y., M. Haritani, H. Ishikawa, and N. Yuasa. 1993. Characterization
of a heat-modifiable outer membrane protein of Haemophilus somnus. In-
fect. Immun. 61:1750–1755.
49. Van Alphen, L., L. Havekes, and B. Lugtenberg. 1977. Major outer mem-
VOL. 65, 1997 OmpA PROTEINS OF P. HAEMOLYTICA 217
brane protein d of Escherichia coli K-12. Purification and in vitro activity of
bacteriophage K3 and F-pilus mediated conjugation. FEBS Lett. 75:285–290.
50. Van Alphen, L., T. Riemens, J. Poolman, and H. C. Zanen. 1983. Charac-
teristics of major outer membrane proteins of Haemophilus influenzae. J.
Bacteriol. 155:878–885.
51. Weiser, J. N., and E. C. Gotschlich. 1991. Outer membrane protein A
(OmpA) contributes to serum resistance and pathogenicity of Escherichia
coli K-1. Infect. Immun. 59:2252–2258.
52. Wilson, M. E. 1991. The heat-modifiable outer membrane protein of Acti-
nobacillus actinomycetemcomitans: relationship to OmpA proteins. Infect.
Immun. 59:2505–2507.
53. Woodruff, W. A., T. R. Parr, R. E. W. Hancock, L. F. Hanne, T. I. Nicas, and
B. H. Iglewski. 1986. Expression in Escherichia coli and function of Pseudo-
monas aeruginosa outer membrane protein F. J. Bacteriol. 167:473–479.
54. Woodruff, W. A., and R. E. W. Hancock. 1989. Pseudomonas aeruginosa outer
membrane protein F: structural role and relationship to the Escherichia coli
OmpA protein. J. Bacteriol. 171:3304–3309.
55. Yates, W. D. G. 1982. A review of infectious bovine rhinotracheitis, shipping
fever pneumonia and viral bacterial synergism in respiratory disease of
cattle. Can. J. Comp. Med. 46:225–263.
Editor: P. E. Orndorff
218 MAHASRESHTI ET AL. INFECT. IMMUN.
